These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2226145)

  • 21. Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment.
    Lisziewicz J; Sun D; Klotman M; Agrawal S; Zamecnik P; Gallo R
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11209-13. PubMed ID: 1454800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
    King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
    J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Suppression of the reproduction of the human immunodeficiency virus (HIV) with a cytokine-like antiviral factor].
    Gribkova NV; Eremin VF; Votiakov VI; Shchelkanov MIu; Pashkova TA; Karamov EV
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (5):27-9. PubMed ID: 9082722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense oligodeoxynucleotide complementary to CXCR4 mRNA block replication of HIV-1 in COS cells.
    Kusunoki A; Wada A; Kurosaki N; Kimura T; Takai K; Yamamoto N; Takaku H
    Nucleosides Nucleotides; 1999; 18(6-7):1705-8. PubMed ID: 10474251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV-1 genome dimerization and inhibit virus replication.
    Elmén J; Zhang HY; Zuber B; Ljungberg K; Wahren B; Wahlestedt C; Liang Z
    FEBS Lett; 2004 Dec; 578(3):285-90. PubMed ID: 15589834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of herpes simplex virus type-1.
    Peyman A; Helsberg M; Kretzschmar G; Mag M; Grabley S; Uhlmann E
    Biol Chem Hoppe Seyler; 1995 Mar; 376(3):195-8. PubMed ID: 7612196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of human immunodeficiency virus-1 proliferation by liposome-encapsulated sense DNA to the 5' tat splice acceptor site.
    Sullivan SM; Gieseler RK; Lenzner S; Ruppert J; Gabrysiak TG; Peters JH; Cox G; Richer L; Martin WJ; Scolaro MJ
    Antisense Res Dev; 1992; 2(3):187-97. PubMed ID: 1490070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The inhibiting action of interferon inducers on the multiplication of the human immunodeficiency virus].
    Nosik NN; Nosik DN; Kuznetsova NV
    Vopr Virusol; 1992; 37(2):92-4. PubMed ID: 1441434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of HIV replication by immunoliposomal antisense oligonucleotide.
    Selvam MP; Buck SM; Blay RA; Mayner RE; Mied PA; Epstein JS
    Antiviral Res; 1996 Dec; 33(1):11-20. PubMed ID: 8955849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups.
    Svinarchuk FP; Konevetz DA; Pliasunova OA; Pokrovsky AG; Vlassov VV
    Biochimie; 1993; 75(1-2):49-54. PubMed ID: 8504177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of 2,3,7,8-tetrachlorodibenzo-para-dioxin on the reproduction of human immunodeficiency virus in lymphoid cell cultures].
    Pokrovskiĭ AG; Chernykh AI; Chaplygina SR; Iastrebova ON; Tsyrlov IB
    Dokl Akad Nauk SSSR; 1990; 313(3):723-5. PubMed ID: 1701377
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of human immunodeficiency virus (HIV-1) replication by synthetic oligo-RNA derivatives.
    Shibahara S; Mukai S; Morisawa H; Nakashima H; Kobayashi S; Yamamoto N
    Nucleic Acids Res; 1989 Jan; 17(1):239-52. PubMed ID: 2911465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense inhibitors of HIV: problems and perspectives.
    Degols G; Leonetti JP; Milhaud P; Mechti N; Lebleu B
    Antiviral Res; 1992 Apr; 17(4):279-87. PubMed ID: 1642480
    [No Abstract]   [Full Text] [Related]  

  • 34. Antisense has growing pains.
    Gura T
    Science; 1995 Oct; 270(5236):575-7. PubMed ID: 7570012
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of immunocorrective agents on the production of the human immunodeficiency virus type 1 in vitro].
    Nesterchuk SL; Barinskiĭ IF
    Vopr Virusol; 1989; 34(2):171-4. PubMed ID: 2788329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HIV replication is reduced with pentoxifylline administration].
    Minerva Pediatr; 1992 Mar; 44(3):XV-XVI. PubMed ID: 1518490
    [No Abstract]   [Full Text] [Related]  

  • 37. Current concepts in antisense drug design.
    Milligan JF; Matteucci MD; Martin JC
    J Med Chem; 1993 Jul; 36(14):1923-37. PubMed ID: 8336333
    [No Abstract]   [Full Text] [Related]  

  • 38. Water-soluble block polycations as carriers for oligonucleotide delivery.
    Kabanov AV; Vinogradov SV; Suzdaltseva YG; Alakhov VYu
    Bioconjug Chem; 1995; 6(6):639-43. PubMed ID: 8608176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replication of the human immunodeficiency virus type 1 is inhibited in human cells with antisense RNA expression.
    Sczakiel G; Rittner K; Homann M; Pawlita M
    Biochem Soc Trans; 1991 Nov; 19(4):437S. PubMed ID: 1794555
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of HIV replication by derivatives of naphthalenedisulfonic acids.
    Mohan P; Sun D; Thornton A; Sarin PS
    AIDS; 1990 Aug; 4(8):821-2. PubMed ID: 2261142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.